Cargando…
Possible Novel Therapeutic Targets in Lymphangioleiomyomatosis Treatment
Lymphangioleiomyomatosis (LAM) is a rare systemic neoplastic disease that exclusively happens in women. Studies focusing on LAM and tuberous sclerosis complex (TSC) have made great progress in understanding the pathogenesis and searching for treatment. The inactive mutation of TSC1 or TSC2 is found...
Autores principales: | Song, Xixi, Cai, Hui, Yang, Chengyu, Xue, Xiaomin, Wang, Jian, Mo, Yuqing, Zhu, Mengchan, Zhu, Guiping, Ye, Ling, Jin, Meiling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542236/ https://www.ncbi.nlm.nih.gov/pubmed/33072782 http://dx.doi.org/10.3389/fmed.2020.554134 |
Ejemplares similares
-
SERPINB10 contributes to asthma by inhibiting the apoptosis of allergenic Th2 cells
por: Mo, Yuqing, et al.
Publicado: (2021) -
ROS-Responsive miR-150-5p Downregulation Contributes to Cigarette Smoke-Induced COPD via Targeting IRE1α
por: Zhu, Mengchan, et al.
Publicado: (2022) -
Small Proline-Rich Protein 3 Regulates IL-33/ILC2 Axis to Promote Allergic Airway Inflammation
por: Zhu, Guiping, et al.
Publicado: (2022) -
Clinical Characteristics and Prognosis of Allergic Bronchopulmonary Aspergillosis: A Retrospective Cohort Study
por: Zeng, Yingying, et al.
Publicado: (2022) -
Edaravone Attenuated Particulate Matter-Induced Lung Inflammation by Inhibiting ROS-NF-κB Signaling Pathway
por: Zeng, Yingying, et al.
Publicado: (2022)